CCRN practice question 7 of 25

The most appropriate therapy for carboxyhemoglobinemia is

Full set: 150 questions
Answer options
A: 100% O2 administration. Correct answer
B: inhaled corticosteroids.
C: hyperventilation.
D: aerosolized beta-agonists.
Correct Answer:
A. 100% O2 administration.
Explanation

Carboxyhemoglobinemia results from carbon monoxide (CO) poisoning. CO has an affinity for hemoglobin that is over 200 times greater than that of oxygen, forming carboxyhemoglobin (COHb) and preventing oxygen transport to tissues. The primary treatment is to displace CO from hemoglobin. Administering 100% oxygen via a non-rebreather mask significantly increases the partial pressure of dissolved oxygen in the blood. This accelerates the dissociation of CO from hemoglobin, shortening the half-life of COHb from approximately 4-6 hours on room air to 60-90 minutes, thereby restoring the blood's oxygen-carrying capacity.

Why Incorrect

B. Inhaled corticosteroids are anti-inflammatory agents and have no role in reversing the binding of carbon monoxide to hemoglobin.
C. While patients may hyperventilate spontaneously, inducing it is not the primary therapy; the core problem is hemoglobin binding, not inadequate ventilation.
D. Aerosolized beta-agonists are bronchodilators used for conditions like asthma and do not affect the pathophysiology of carbon monoxide poisoning.

References

1. Urden, L. D., Stacy, K. M., & Lough, M. E. (2021). Urden's Critical Care Nursing: Diagnosis and Management (9th ed.). Elsevier. Chapter 19, Pulmonary Disorders, p. 431.

2. Hampson, N. B., Piantadosi, C. A., Thom, S. R., & Weaver, L. K. (2012). Practice recommendations in the diagnosis, management, and prevention of carbon monoxide poisoning. American Journal of Respiratory and Critical Care Medicine, 186(11), 1095–1101. https://doi.org/10.1164/rccm.201207-1284CI

3. Rose, J. J., Wang, L., Xu, Q., McTiernan, C. F., Shiva, S., Tejero, J., & Gladwin, M. T. (2017). Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy. American Journal of Respiratory and Critical Care Medicine, 195(5), 596–606. https://doi.org/10.1164/rccm.201606-1179CI

Scroll to Top